期刊文献+

25-羟基维生素D_3人工完全抗原的合成与鉴定 被引量:3

Synthesis and identification of artificial complete antigen 25-hydroxyvitamin D_3
下载PDF
导出
摘要 目的:合成25-羟基维生素D3人工完全抗原,并制备抗25-羟基维生素D3的特异性抗体。方法:将25-羟基维生素D3进行化学修饰加入羧基活性基团,合成具有半抗原结构特征的25-羟基维生素D3-半琥珀酸酯。采用碳二亚胺法,将25-羟基维生素D3-半琥珀酸酯,分别与牛血清白蛋白(BSA)和卵清蛋白(OVA)偶联,合成人工完全抗原25-羟基维生素D3-半琥珀酸酯-BSA和25-羟基维生素D3-半琥珀酸酯-OVA。通过紫外吸收光谱,SDS-PAGE和MALDI-TOF进行偶联鉴定。用25-羟基维生素D3-半琥珀酸酯-BSA免疫小鼠,获得抗25-羟基维生素D3抗体免疫血清。结果:25-羟基维生素D3-半琥珀酸酯与BSA的偶联比为(12±0.16)∶1,免疫小鼠后获得高效价(效价为6.25×10-4)的抗体,且标准品浓度在37.5~600 ng/mL范围具有显著的竞争性线性关系,检测的灵敏度为37.5 ng/mL。结论:成功合成了25-羟基维生素D3人工完全抗原,制备出25-羟基维生素D3的抗体且其线性关系显著,灵敏度较高,为进一步研制检测25-羟基维生素D3的试剂盒奠定了基础。 AIM: To synthesize the 25-hydroxyvitamin D3 artificial complete antigen and to prepare the specific antibody against 25-hydroxyvitamin D3. METHODS: The active group carboxyl was introduced into 25-hydroxyvitamin D3 and formed 25-hydroxyvitamin D3-hemisuccinate which pos- sessed the structure of the hapten by chemical modification. The EDC method was applied to conjugate 25-hydroxyvitamin D3-hemisuccinate to bovine serum albumin as an artifi- cial immunogen. The coating antigen 25-hydroxyvitamin D3- hemisuccinate-OVA was obtained in the same way. Ultraviolet, SDS-PAGE and MALDI-TOF were used to identify 25- hydroxyvitamin D3-hemisuccinate-BSA. RESULTS: BALB/c mice were immunized with 25-hydroxyvitamin D3-hemisuccinate-BSA to generate the polyclonal antibody of the 25- hydroxyvitamin D3 worth high titer and the immunogen, 25- hydroxyvitamin D3-hemisuccinate-BSA, was successfully prepared with coupling ratio (12 ±0.16):1( N =3) coupling. CONCLUSION: The high titer and good sensitivity of anti- 25-hydroxyvitamin D3 antibody are produced in sera immunized BALB/c mice, which made it possible to develop a clinical diagnostics for illness.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2011年第11期1173-1175,1179,共4页 Chinese Journal of Cellular and Molecular Immunology
关键词 25-羟基维生素D3 半抗原-[C-3]-载体蛋白偶联 人工完全抗原 25-hydroxyvitamin D3 hapten-[ C-3 ] -carrier conjugates artificial complete antigen
  • 相关文献

参考文献11

  • 1Feskanich D, Ma J, Fuchs CS, et al. Plasma vitamin D metabolites and risk of colorectal cancer in women[ J]. Cancer Epidemiol Binmarkers Prey, 2004, 13(9): 1502-1508.
  • 2Janowsky EC, Lester GE, Weinberg CR, et al. Association between low levels of 1, 25-dihydroxyvitamin D and breast cancer risk [ J ]. Public Health Nutr, 1999, 2(3) : 283 -291.
  • 3Ahonen MH, Tenkanen L, Teppo L, et al. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels(Finland) [ J]. Cancer Causes Control, 2000, 11 (9) : 847-852.
  • 4Holick MF. Calcium plus vitamin D and the risk of colorectal cancer [J]. N Engl J Med, 2006, 354(2) : 2287 -2288.
  • 5Giovanucci E, Liu Y, Rimm EB, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men [ J ]. J Natl Cancer Inst, 2006, 98:451 -459.
  • 6Cantorna MT, Mahon BD. Mounting Evidence for vitamin D as an En-vironmental factor affecting autoimmune disease prevalence [ J ]. Exp Biol Med, 2004, 229(11): 1136-1142.
  • 7Holick MF. Vitamin D deficiency [ J]. N Engl J Med, 2007, 357 (3) : 266 -281.
  • 8Norihiro K, Kaoru U, Junicbi K, et al. Production and specificity of antisera raised against 25-hydroxyvitamin D3-[ C-3 ] -bovine serum albumin conjugates[J]. Steroids, 1992, 57:488-493.
  • 9Itaru Y, Eiji M. Monoclonal Antibody for Calcitriol[J]. J. Biochem, 1985, 98, 991 -998.
  • 10Hosoda H, Kawamura N, Nmnbara T. Effect of bridge heterologous combination on sensitivity in enzyme immunoassay for cortisol [ J]. Chem Pharm Bull (Tokyo) , 1981, 29(7) : 1969 -1974.

同被引文献21

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部